These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26918625)

  • 1. Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.
    Malfatti MA; Kuhn EA; Turteltaub KW; Vickers SM; Jensen EH; Strayer L; Anderson KE
    Chem Res Toxicol; 2016 Mar; 29(3):352-8. PubMed ID: 26918625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
    Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
    Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.
    Lynch AM; Knize MG; Boobis AR; Gooderham NJ; Davies DS; Murray S
    Cancer Res; 1992 Nov; 52(22):6216-23. PubMed ID: 1423264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice.
    Turesky RJ; Bessette EE; Dunbar D; Liberman RG; Skipper PL
    Chem Res Toxicol; 2012 Feb; 25(2):410-21. PubMed ID: 22118226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
    Frantz CE; Bangerter C; Fultz E; Mayer KM; Vogel JS; Turteltaub KW
    Carcinogenesis; 1995 Feb; 16(2):367-73. PubMed ID: 7859370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of the food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rats.
    Sjödin P; Wallin H; Alexander J; Jägerstad M
    Carcinogenesis; 1989 Jul; 10(7):1269-75. PubMed ID: 2661045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans.
    Turesky RJ; Garner RC; Welti DH; Richoz J; Leveson SH; Dingley KH; Turteltaub KW; Fay LB
    Chem Res Toxicol; 1998 Mar; 11(3):217-25. PubMed ID: 9544620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
    Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
    Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.
    Gu D; McNaughton L; Lemaster D; Lake BG; Gooderham NJ; Kadlubar FF; Turesky RJ
    Chem Res Toxicol; 2010 Apr; 23(4):788-801. PubMed ID: 20192249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
    Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
    Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeIQx (2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline): metabolism in humans and urinary metabolites in human populations.
    Tannenbaum SR; Stillwell WG; Ji H; Skipper PL; Yu MC; Ross RK; Henderson BE; Turesky RJ; Gross GA
    Princess Takamatsu Symp; 1995; 23():197-206. PubMed ID: 8844811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomonitoring of heterocyclic aromatic amine metabolites in human urine.
    Stillwell WG; Turesky RJ; Sinha R; Skipper PL; Tannenbaum SR
    Cancer Lett; 1999 Sep; 143(2):145-8. PubMed ID: 10503894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: a conformational analysis of its major DNA adduct and comparison with the 2-amino-3-methylimidazo[4,5-f]quinoline adduct.
    Gauvin J; Broyde S; Shapiro R
    Chem Res Toxicol; 2001 May; 14(5):476-82. PubMed ID: 11368544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates.
    Snyderwine EG; Welti DH; Davis CD; Fay LB; Turesky RJ
    Carcinogenesis; 1995 Jun; 16(6):1377-84. PubMed ID: 7788858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.
    Davis CD; Dacquel EJ; Schut HA; Thorgeirsson SS; Snyderwine EG
    Mutat Res; 1996 Sep; 356(2):287-96. PubMed ID: 8841498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can creatine supplementation form carcinogenic heterocyclic amines in humans?
    Pereira RT; Dörr FA; Pinto E; Solis MY; Artioli GG; Fernandes AL; Murai IH; Dantas WS; Seguro AC; Santinho MA; Roschel H; Carpentier A; Poortmans JR; Gualano B
    J Physiol; 2015 Sep; 593(17):3959-71. PubMed ID: 26148133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeIQx-DNA adduct formation in rodent and human tissues at low doses.
    Turteltaub KW; Mauthe RJ; Dingley KH; Vogel JS; Frantz CE; Garner RC; Shen N
    Mutat Res; 1997 May; 376(1-2):243-52. PubMed ID: 9202761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
    Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
    Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine.
    Stillwell WG; Turesky RJ; Sinha R; Tannenbaum SR
    Cancer Res; 1999 Oct; 59(20):5154-9. PubMed ID: 10537291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.